Letter: for improved prognostic value, use MAFLD

Aliment Pharmacol Ther. 2023 Jul;58(1):147-148. doi: 10.1111/apt.17558.

Authors

Harry Crane¹, Guy D Eslick², Jacob George¹

Affiliations

¹ Storr Liver Centre, Westmead Institute for Medical Research, Westmead Hospital and University of Sydney, Westmead, New South Wales, Australia.
² NHMRC Centre for Research Excellence in Digestive Diseases, Hunter Medical Research Institute (HMRI), The University of Newcastle, Newcastle, New South Wales, Australia.

PMID: 37307558
DOI: 10.1111/apt.17558

No abstract available

Publication types

Letter
Comment

MeSH terms

Fatty Liver* / diagnosis
Humans
Prognosis